These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36793351)
21. Synthesis of Self-Targeted Carbon Dot with Ultrahigh Quantum Yield for Detection and Therapy of Cancer. Azizi M; Valizadeh H; Shahgolzari M; Talebi M; Baybordi E; Dadpour MR; Salehi R; Mehrmohammadi M ACS Omega; 2020 Sep; 5(38):24628-24638. PubMed ID: 33015480 [TBL] [Abstract][Full Text] [Related]
22. Development of an albumin decorated lipid-polymer hybrid nanoparticle for simultaneous delivery of methotrexate and conferone to cancer cells. Khalili L; Dehghan G; Hosseinpour Feizi MA; Sheibani N; Hamishekar H Int J Pharm; 2021 Apr; 599():120421. PubMed ID: 33676992 [TBL] [Abstract][Full Text] [Related]
23. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition. Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671 [TBL] [Abstract][Full Text] [Related]
24. Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy. Abedi Gaballu F; Cho WC; Dehghan G; Zarebkohan A; Baradaran B; Mansoori B; Abbaspour-Ravasjani S; Mohammadi A; Sheibani N; Aghanejad A; Ezzati Nazhad Dolatabadi J Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356120 [TBL] [Abstract][Full Text] [Related]
25. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles. Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161 [TBL] [Abstract][Full Text] [Related]
26. Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A "Raisin-Cake"-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery. Farjadian F; Faghih Z; Fakhimi M; Iranpour P; Mohammadi-Samani S; Doroudian M Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896251 [TBL] [Abstract][Full Text] [Related]
27. Novel Methotrexate-Ciprofloxacin Loaded Alginate-Clay Based Nanocomposite as Anticancer and Antibacterial Co-Drug Delivery System. Mahkam M; Bazmi Zeynabad F; Alizadeh E; Rahimi M; Rahimi F; Salehi R Adv Pharm Bull; 2021 May; 11(3):477-489. PubMed ID: 34513622 [No Abstract] [Full Text] [Related]
28. Synthesis of New Antibacterial Cubane-based Nanocomposite and its Application in Combination Cancer Therapy. Zakerzadeh E; Salehi R; Mahkam M Anticancer Agents Med Chem; 2018 Feb; 17(14):1898-1914. PubMed ID: 28530541 [TBL] [Abstract][Full Text] [Related]
29. Self-assembling water-soluble polymethacrylate-MTX conjugates: The significance of macromolecules architecture on drug conjugation efficiency, the final shape of particles, and drug release. Bernaczek K; Mielańczyk A; Mielańczyk Ł; Neugebauer D; Grzywna ZJ J Biomed Mater Res B Appl Biomater; 2019 Nov; 107(8):2476-2487. PubMed ID: 30773803 [TBL] [Abstract][Full Text] [Related]
30. Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application. Katiyar SS; Kushwah V; Dora CP; Jain S Colloids Surf B Biointerfaces; 2019 Feb; 174():501-510. PubMed ID: 30497012 [TBL] [Abstract][Full Text] [Related]
31. Core-shell Pluronic F127/chitosan based nanoparticles for effective delivery of methotrexate in the management of rheumatoid arthritis. Shafiq A; Madni A; Khan S; Sultana H; Sumaira ; Shah H; Khan S; Rehman S; Nawaz M Int J Biol Macromol; 2022 Jul; 213():465-477. PubMed ID: 35661673 [TBL] [Abstract][Full Text] [Related]
32. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study. Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155 [TBL] [Abstract][Full Text] [Related]
33. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells. Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875 [TBL] [Abstract][Full Text] [Related]
34. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097 [TBL] [Abstract][Full Text] [Related]
35. Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy. Zhou Y; Yang L; Lyu Y; Wu D; Zhu Y; Li J; Jiang D; Xin X; Yin L Int J Nanomedicine; 2023; 18():899-915. PubMed ID: 36824414 [TBL] [Abstract][Full Text] [Related]
36. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy. Ferreira M; Chaves LL; Lima SA; Reis S Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145 [TBL] [Abstract][Full Text] [Related]
37. Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells. Nosrati H; Salehiabar M; Davaran S; Danafar H; Manjili HK Drug Dev Ind Pharm; 2018 Jun; 44(6):886-894. PubMed ID: 29280388 [TBL] [Abstract][Full Text] [Related]
38. Methotrexate-conjugated zinc oxide nanoparticles exert a substantially improved cytotoxic effect on lung cancer cells by inducing apoptosis. Mishra P; Ali Ahmad MF; Al-Keridis LA; Saeed M; Alshammari N; Alabdallah NM; Tiwari RK; Ahmad A; Verma M; Fatima S; Ansari IA Front Pharmacol; 2023; 14():1194578. PubMed ID: 37915418 [TBL] [Abstract][Full Text] [Related]
39. A multilayer hollow nanocarrier for pulmonary co-drug delivery of methotrexate and doxorubicin in the form of dry powder inhalation formulation. Nozohouri S; Salehi R; Ghanbarzadeh S; Adibkia K; Hamishehkar H Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():752-761. PubMed ID: 30889750 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment. Xu D; Lu ST; Li YS; Baidya A; Mei H; He Y; Wu B Drug Des Devel Ther; 2018; 12():3301-3309. PubMed ID: 30323562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]